The Mesothelioma Center News – Page 19
-
news
Legislation & LitigationCities and counties throughout the country are paying the price for failing to adhere to the tightening safety protocols that cover the handling and… -
news
Research & Clinical TrialsNovel Clinical Trial Helping Late-Stage Mesothelioma Patients
Late-stage patients with pleural mesothelioma have survived longer than anticipated — with good quality of life — in a phase I clinical… -
news
Asbestos Exposure & BansSudden Rise in Asbestos Imports as Ban Draws Closer
Importation of raw chrysotile asbestos into the United States increased dramatically earlier this year, despite the growing movement toward tighter regulation and a potential… -
news
Research & Clinical TrialsCarbone: Building the Guide to BAP1 Mutation in Mesothelioma
Over the years, I have “collected” many families affected by the BAP1 cancer syndrome, a novel medical condition we discovered in 2011. Pathogenic germline… -
news
Research & Clinical TrialsTargeted Therapy Making Progress with Pleural Mesothelioma
Future treatment of pleural mesothelioma cancer continued its move toward a more personalized, targeted approach with the latest results from a multi-center clinical… -
news
Veterans & MilitaryVeterans Getting Closer to Justice at Camp Lejeune
Veterans and their families who were exposed to the contaminated drinking water at Marine Corps Base Camp Lejeune in North Carolina may soon find… -
news
Asbestos Exposure & BansIncreasing Numbers of Women Dying from Malignant Mesothelioma
The number of women dying annually from malignant mesothelioma climbed by 25% over the past two decades, despite a nationwide drop in the… -
news
Asbestos Exposure & BansEPA Proposes Stricter Asbestos Reporting
The United States Environmental Protection Agency has proposed a new rule that would require much stricter reporting and record keeping for all uses… -
news
Research & Clinical TrialsNew Mesothelioma Immunotherapy Clinical Trial Opens at MD Anderson
The acclaimed MD Anderson Cancer Center in Houston is opening a phase II clinical trial involving a new immunotherapy drug aimed specifically at… -
news
Asbestos Exposure & BansJohnson & Johnson to Continue Global Sale of Talc-Based Baby Powder
Johnson & Johnson will continue selling its iconic talc-based baby powder outside the United States and Canada after shareholders rejected a proposal that…